Clinical Trial: Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST)

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Pharmacokinetic Study of Nilotinib in Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor Showing Failure to Both Imatinib and Sunitinib

Brief Summary: In patients who are receiving nilotinib, nilotinib plasma levels will be measured after 1 month of nilotinib treatment. The relationship between surgery type and nilotinib pharmakokinetic properties will be investigated in this study.

Detailed Summary:
Sponsor: Asan Medical Center

Current Primary Outcome: nilotinib pharmacokinetics [ Time Frame: Up to 3years ]

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Asan Medical Center

Dates:
Date Received: September 11, 2009
Date Started: January 2009
Date Completion:
Last Updated: July 3, 2013
Last Verified: July 2013